Cell facilitation promotes growth and survival under drug pressure in breast cancer

[1]  Jeffrey T. Chang,et al.  Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy , 2021, Nature Cancer.

[2]  Joel s. Brown,et al.  The Evolution and Ecology of Resistance in Cancer Therapy. , 2020, Cold Spring Harbor perspectives in medicine.

[3]  P. Neven,et al.  Ribociclib plus fulvestrant in the treatment of breast cancer , 2020, Expert review of anticancer therapy.

[4]  Lance T. Pflieger,et al.  Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model , 2020, Cancer Cell International.

[5]  P. Spellman,et al.  Transient commensal clonal interactions can drive tumor metastasis , 2020, Nature Communications.

[6]  H. Borges,et al.  Highlights in Resistance Mechanism Pathways for Combination Therapy , 2019, Cells.

[7]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[8]  P. ten Dijke,et al.  TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis , 2019, International journal of molecular sciences.

[9]  Allon M Klein,et al.  Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data. , 2019, Cell systems.

[10]  B. Park,et al.  Estrogen-independent Myc overexpression confers endocrine therapy resistance on breast cancer cells expressing ERαY537S and ERαD538G mutations. , 2019, Cancer letters.

[11]  Marco Archetti,et al.  Cooperation among cancer cells: applying game theory to cancer , 2018, Nature Reviews Cancer.

[12]  C. Brezden-Masley,et al.  Overcoming endocrine resistance in hormone receptor-positive breast cancer. , 2018, Current oncology.

[13]  Brent S. Pedersen,et al.  Combating subclonal evolution of resistant cancer phenotypes , 2017, Nature Communications.

[14]  N. McGranahan,et al.  Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.

[15]  Jiqiang Guo,et al.  Stan: A Probabilistic Programming Language. , 2017, Journal of statistical software.

[16]  A. Gelman,et al.  Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC , 2016, Statistics and Computing.

[17]  M. Zvelebil,et al.  Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer , 2016, Breast Cancer Research.

[18]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[19]  P. Linsley,et al.  MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data , 2015, Genome Biology.

[20]  W. Fan,et al.  Endocrine therapy resistance in breast cancer: current status, possible mechanisms and overcoming strategies. , 2015, Future medicinal chemistry.

[21]  Aki Vehtari,et al.  Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC , 2015, Statistics and Computing.

[22]  M. Archetti,et al.  Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrine pancreatic cancer , 2015, Proceedings of the National Academy of Sciences.

[23]  R. Clarke,et al.  MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer , 2014, Molecular Cancer.

[24]  S. Gestl,et al.  Tumor cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers , 2014, Nature.

[25]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[26]  J. Pepper,et al.  Drugs that target pathogen public goods are robust against evolved drug resistance , 2012, Evolutionary applications.

[27]  Rachel Schiff,et al.  Mechanisms of endocrine resistance in breast cancer. , 2011, Annual review of medicine.

[28]  Olufunmilayo I Olopade,et al.  MYC and Breast Cancer. , 2010, Genes & cancer.

[29]  Robert Axelrod,et al.  Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. , 2008, Translational oncology.

[30]  Sonia Kéfi,et al.  Evolution of Local Facilitation in Arid Ecosystems , 2008, The American Naturalist.

[31]  A. D. de Roos,et al.  Simplifying a physiologically structured population model to a stage-structured biomass model. , 2008, Theoretical population biology.

[32]  Margaret Gardiner-Garden,et al.  c-Myc overexpression and endocrine resistance in breast cancer , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[33]  Adam L. Meadows,et al.  Estradiol stimulates the biosynthetic pathways of breast cancer cells: detection by metabolic flux analysis. , 2006, Metabolic engineering.

[34]  Kyle Summers,et al.  Evolutionary biology of cancer. , 2005, Trends in ecology & evolution.

[35]  O. Sieber,et al.  Tissue, cell and stage specificity of (epi)mutations in cancers , 2005, Nature Reviews Cancer.

[36]  Marcel Garcia,et al.  Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. , 2004, Critical reviews in oncology/hematology.

[37]  Margo I. Wilson,et al.  Nominal kinship cues facilitate altruism , 2002, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[38]  Y. Geng,et al.  Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.

[39]  J Baranyi,et al.  A dynamic approach to predicting bacterial growth in food. , 1994, International journal of food microbiology.

[40]  M. Bertness,et al.  Positive interactions in communities. , 1994, Trends in ecology & evolution.

[41]  G. Greene,et al.  Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018. , 1985, Endocrinology.

[42]  Hee Jun Choi,et al.  EGFR is a Therapeutic Target in Hormone Receptor-Positive Breast Cancer. , 2019, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

[43]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[44]  Tiansen Li,et al.  Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. , 2006, Cancer cell.

[45]  Yan Geng,et al.  Requirement for CDK4 kinase function in breast cancer. , 2006, Cancer cell.

[46]  J. Keener,et al.  A mathematical model for quorum sensing in Pseudomonas aeruginosa , 2001, Bulletin of mathematical biology.

[47]  M. Caldwell,et al.  Hydraulic lift: consequences of water efflux from the roots of plants , 1998, Oecologia.

[48]  G. Heppner,et al.  Cancer cell societies and tumor progression , 1993, Stem cells.